The Cigna Group (CI)
NYSE: CI · Real-Time Price · USD
272.21
-5.73 (-2.06%)
At close: Jan 16, 2026, 4:00 PM EST
272.95
+0.74 (0.27%)
After-hours: Jan 16, 2026, 7:52 PM EST
The Cigna Group Market Cap
The Cigna Group has a market cap or net worth of $72.71 billion as of January 16, 2026. Its market cap has decreased by -5.33% in one year.
Market Cap
72.71B
Enterprise Value
99.85B
1-Year Change
-5.33%
Ranking
Category
Stock Price
$272.21
Market Cap Chart
Since December 1, 1998, The Cigna Group's market cap has increased from $15.96B to $72.71B, an increase of 355.51%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 72.71B | -1.10% |
| Dec 31, 2025 | 73.52B | -4.28% |
| Dec 31, 2024 | 76.81B | -12.34% |
| Dec 29, 2023 | 87.63B | -13.50% |
| Dec 30, 2022 | 101.30B | 33.11% |
| Dec 31, 2021 | 76.11B | 1.19% |
| Dec 31, 2020 | 75.21B | -1.51% |
| Dec 31, 2019 | 76.36B | 65.10% |
| Dec 31, 2018 | 46.25B | -7.63% |
| Dec 29, 2017 | 50.07B | 46.21% |
| Dec 30, 2016 | 34.25B | -9.15% |
| Dec 31, 2015 | 37.69B | 40.03% |
| Dec 31, 2014 | 26.92B | 11.33% |
| Dec 31, 2013 | 24.18B | 58.21% |
| Dec 31, 2012 | 15.28B | 34.67% |
| Dec 30, 2011 | 11.35B | 14.27% |
| Dec 31, 2010 | 9.93B | 2.98% |
| Dec 31, 2009 | 9.64B | 110.64% |
| Dec 31, 2008 | 4.58B | -69.48% |
| Dec 31, 2007 | 15.00B | 11.15% |
| Dec 29, 2006 | 13.50B | -3.95% |
| Dec 30, 2005 | 14.05B | 28.29% |
| Dec 31, 2004 | 10.95B | 35.56% |
| Dec 31, 2003 | 8.08B | 40.94% |
| Dec 31, 2002 | 5.73B | -57.22% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |